Incepta Pharmaceuticals Ltd.

Incepta Pharmaceuticals Ltd., established in 1999, is a leading pharmaceutical company in Bangladesh, employing over 10,000 professionals across diverse disciplines. Renowned for its innovative research, Incepta has pioneered the introduction of 255 new products to the market and currently offers 1,279 generic pharmaceutical presentations. The company produces nearly all types of dosage forms and exports to over 100 countries, including the UK, Germany, and Turkey. It holds numerous regulatory certifications, such as MHRA, European Union, WHO-PQ, and Turkey's GMP. Incepta’s collaborative ventures include partnerships with the Bill & Melinda Gates Foundation, Clinton Health Access Initiative (CHAI), USAID, and Marie Stopes International, showcasing its commitment to improving global healthcare.

The Vaccine Division, established in 2011, exemplifies Incepta’s dedication to providing high-quality and affordable vaccines. With cutting-edge facilities featuring four filling lines, three suites for bulk antigen production, and advanced R&D capabilities, the division produces up to 180 million single doses annually and up to 1 billion doses for multi-dose vials. Incepta currently manufactures 12 vaccines, including four developed from its own bulk antigens: meningococcal polysaccharide vaccine (ACYW135), hepatitis B vaccine, oral cholera vaccine, and rabies vaccine. The typhoid conjugate vaccine is slated for imminent launch, and its robust pipeline includes vaccines under development for HPV4, PCV, dengue, and rotavirus. The facility utilizes state-of-the-art fermenters and downstream processing equipment sourced from reputable international manufacturers.

Incepta’s global collaborations further solidify its reputation as a key player in healthcare innovation. Partnerships with organizations such as IVI, PATH, Imperial College of London, ICDDR,B, and Oxford University reflect its commitment to advancing global health initiatives. With diversified divisions in areas such as hygiene, hospicare, animal health, and herbal and nutricare products, Incepta continues to expand its impact on healthcare. By leveraging advanced technology, global partnerships, and a dedicated workforce, Incepta Pharmaceuticals strives to make a meaningful contribution to both local and international communities.